|
1
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Spira A and Ettinger DS: Multidisciplinary
management of lung cancer. N Engl J Med. 350:379–392. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
de las Peñas R, Sanchez-Ronco M, Alberola
V, et al: Polymorphisms in DNA repair genes modulate survival in
cisplatin/gemcitabine-treated non-small-cell lung cancer patients.
Ann Oncol. 17:668–675. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Logan CY and Nusse R: The Wnt signaling
pathway in development and disease. Annu Rev Cell Dev Biol.
20:781–810. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mazieres J, He B, You L, Xu Z and Jablons
DM: Wnt signaling in lung cancer. Cancer Lett. 222:1–10. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Klaus A and Birchmeier W: Wnt signalling
and its impact on development and cancer. Nat Rev Cancer.
8:387–398. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang H, Fan L, Xia X, et al: Silencing
Wnt2B by siRNA interference inhibits metastasis and enhances
chemotherapy sensitivity in ovarian cancer. Int J Gynecol Cancer.
22:755–761. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dowejko A, Bauer R, Bauer K,
Müller-Richter UD and Reichert TE: The human HECA interacts with
cyclins and CDKs to antagonize Wnt-mediated proliferation and
chemo-resistance of head and neck cancer cells. Exp Cell Res.
318:489–499. 2012. View Article : Google Scholar
|
|
9
|
Su HY, Lai HC, Lin YW, et al: Epigenetic
silencing of SFRP5 is related to malignant phenotype and
chemoresistance of ovarian cancer through Wnt signaling pathway.
Int J Cancer. 127:555–567. 2010. View Article : Google Scholar
|
|
10
|
Li Y and Bu G: LRP5/6 in Wnt signaling and
tumorigenesis. Future Oncol. 1:673–681. 2005. View Article : Google Scholar
|
|
11
|
Tsuji T, Miyazaki M, Sakaguchi M, Inoue Y
and Namba M: A REIC gene shows down-regulation in human
immortalized cells and human tumor-derived cell lines. Biochem
Biophys Res Commun. 268:20–24. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ueno K, Hirata H, Majid S, et al: Wnt
antagonist DICKKOPF-3 (Dkk-3) induces apoptosis in human renal cell
carcinoma. Mol Carcinog. 50:449–457. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mizobuchi Y, Matsuzaki K, Kuwayama K, et
al: REIC/Dkk-3 induces cell death in human malignant glioma. Neuro
Oncol. 10:244–253. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hoang BH, Kubo T, Healey JH, et al:
Dickkopf 3 inhibits invasion and motility of Saos-2 osteosarcoma
cells by modulating the Wnt-β-catenin pathway. Cancer Res.
64:2734–2739. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hsieh SY, Hsieh PS, Chiu CT and Chen WY:
Dickkopf-3/REIC functions as a suppressor gene of tumor growth.
Oncogene. 23:9183–9189. 2004.PubMed/NCBI
|
|
16
|
Yue W, Sun Q, Dacic S, et al:
Downregulation of Dkk3 activates β-catenin/TCF-4 signaling in lung
cancer. Carcinogenesis. 29:84–92. 2008. View Article : Google Scholar
|
|
17
|
Tsuji T, Nozaki I, Miyazaki M, et al:
Antiproliferative activity of REIC/Dkk-3 and its significant
down-regulation in non-small-cell lung carcinomas. Biochem Biophys
Res Commun. 289:257–263. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Veeck J and Dahl E: Targeting the Wnt
pathway in cancer: the emerging role of Dickkopf-3. Biochim Biophys
Acta. 1825:18–28. 2012.
|
|
19
|
Gosepath EM, Eckstein N, Hamacher A, et
al: Acquired cisplatin resistance in the head-neck cancer cell line
Cal27 is associated with decreased DKK1 expression and can
partially be reversed by overexpression of DKK1. Int J Cancer.
123:2013–2019. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shou J, Ali-Osman F, Multani AS, Pathak S,
Fedi P and Srivenugopal KS: Human Dkk-1, a gene encoding a Wnt
antagonist, responds to DNA damage and its overexpression
sensitizes brain tumor cells to apoptosis following alkylation
damage of DNA. Oncogene. 21:878–889. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hong WS, Saijo N, Sasaki Y, et al:
Establishment and characterization of cisplatin-resistant sublines
of human lung cancer cell lines. Int J Cancer. 41:462–467. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Coghlan MP, Culbert AA, Cross DA, et al:
Selective small molecule inhibitors of glycogen synthase kinase-3
modulate glycogen metabolism and gene transcription. Chem Biol.
7:793–803. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sato N, Yamabuki T, Takano A, et al: Wnt
inhibitor Dickkopf-1 as a target for passive cancer immunotherapy.
Cancer Res. 70:5326–5336. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Suzuki M, Shigematsu H, Nakajima T, et al:
Synchronous alterations of Wnt and epidermal growth factor receptor
signaling pathways through aberrant methylation and mutation in
non-small cell lung cancer. Clin Cancer Res. 13:6087–6092. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Niida A, Hiroko T, Kasai M, et al: DKK1, a
negative regulator of Wnt signaling, is a target of the
β-catenin/TCF pathway. Oncogene. 23:8520–8526. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen S, Guttridge DC, You Z, et al: Wnt-1
signaling inhibits apoptosis by activating β-catenin/T cell
factor-mediated transcription. J Cell Biol. 152:87–96. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Spencer CA and Groudine M: Control of
c-myc regulation in normal and neoplastic cells. Adv Cancer Res.
56:1–48. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
You Z, Saims D, Chen S, et al: Wnt
signaling promotes oncogenic transformation by inhibiting
c-Myc-induced apoptosis. J Cell Biol. 157:429–440. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
He TC, Sparks AB, Rago C, et al:
Identification of c-MYC as a target of the APC pathway. Science.
281:1509–1512. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tetsu O and McCormick F: β-Catenin
regulates expression of cyclin D1 in colon carcinoma cells. Nature.
398:422–426. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hirata H, Hinoda Y, Nakajima K, et al: Wnt
antagonist DKK1 acts as a tumor suppressor gene that induces
apoptosis and inhibits proliferation in human renal cell carcinoma.
Int J Cancer. 128:1793–1803. 2011. View Article : Google Scholar
|
|
32
|
Perkins C, Kim CN, Fang G and Bhalla KN:
Arsenic induces apoptosis of multidrug-resistant human myeloid
leukemia cells that express Bcr-Abl or overexpress MDR, MRP, Bcl-2,
or Bcl-xL. Blood. 95:1014–1022. 2000.PubMed/NCBI
|
|
33
|
Ambrosini G, Adida C, Sirugo G and Altieri
DC: Induction of apoptosis and inhibition of cell proliferation by
survivin gene targeting. J Biol Chem. 273:11177–11182. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ryan BM, O’Donovan N and Duffy MJ:
Survivin, a new target for anti-cancer therapy. Cancer Treat Rev.
35:553–562. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Olie RA, Simões-Wüst AP, Baumann B, et al:
A novel antisense oligonucleotide targeting survivin expression
induces apoptosis and sensitizes lung cancer cells to chemotherapy.
Cancer Res. 60:2805–2809. 2000.PubMed/NCBI
|
|
36
|
You L, He B, Xu Z, et al: Inhibition of
Wnt-2-mediated signaling induces programmed cell death in
non-small-cell lung cancer cells. Oncogene. 23:6170–6174. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Siddik ZH: Cisplatin: mode of cytotoxic
action and molecular basis of resistance. Oncogene. 22:7265–7279.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Singhal S, Miller D, Ramalingam S and Sun
SY: Gene expression profiling of non-small cell lung cancer. Lung
Cancer. 60:313–324. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
He B and Jablons DM: Wnt signaling in stem
cells and lung cancer. Ernst Schering Found Symp Proc. 2006:27–58.
2006.
|
|
40
|
Teng Y, Wang X, Wang Y and Ma D:
Wnt/β-catenin signaling regulates cancer stem cells in lung cancer
A549 cells. Biochem Biophys Res Comm. 392:373–379. 2010. View Article : Google Scholar
|
|
41
|
Zhang T, Otevrel T, Gao Z, et al: Evidence
that APC regulates survivin expression: a possible mechanism
contributing to the stem cell origin of colon cancer. Cancer Res.
61:8664–8667. 2001.PubMed/NCBI
|
|
42
|
Kim CF, Jackson EL, Woolfenden AE, et al:
Identification of bronchioalveolar stem cells in normal lung and
lung cancer. Cell. 121:823–835. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Niehrs C: Function and biological roles of
the Dickkopf family of Wnt modulators. Oncogene. 25:7496–7481.
2006. View Article : Google Scholar
|
|
44
|
Yang ZR, Dong WG, Lei XF, Liu M and Liu
QS: Overexpression of Dickkopf-3 induces apoptosis through
mitochondrial pathway in human colon cancer. World J Gastroenterol.
18:1590–1601. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Abarzua F, Sakaguchi M, Takaishi M, et al:
Adenovirus-mediated overexpression of REIC/Dkk-3 selectively
induces apoptosis in human prostate cancer cells th rough
activation of c-Jun-NH2-kinase. Cancer Res.
65:9617–9622. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kashiwakura Y, Ochiai K, Watanabe M, et
al: Down-regulation of inhibition of differentiation-1 via
activation of activating transcription factor 3 and Smad regulates
REIC/Dickkopf-3-induced apoptosis. Cancer Res. 68:8333–8341. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Huang M, Wang Y, Sun D, et al:
Identification of genes regulated by Wnt/β-catenin pathway and
involved in apoptosis via micro-array analysis. BMC Cancer. 6:221.
2006. View Article : Google Scholar
|
|
48
|
del Barrantes IB, Montero-Pedrazuela A,
Guadaño-Ferraz A, et al: Generation and characterization of
dickkopf3 mutant mice. Mol Cell Biol. 26:2317–2326. 2006.
View Article : Google Scholar
|
|
49
|
Jung IL, Kang HJ, Kim KC and Kim IG:
Knockdown of the Dickkopf 3 gene induces apoptosis in a lung
adenocarcinoma. Int J Mol Med. 26:33–38. 2010.PubMed/NCBI
|
